Koeppen Katja, Nymon Amanda, Barnaby Roxanna, Bashor Laura, Li Zhongyou, Hampton Thomas H, Liefeld Amanda E, Kolling Fred W, LaCroix Ian S, Gerber Scott A, Hogan Deborah A, Kasetty Swetha, Nadell Carey D, Stanton Bruce A
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755;
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755.
Proc Natl Acad Sci U S A. 2021 Jul 13;118(28). doi: 10.1073/pnas.2105370118.
is an opportunistic pathogen that forms antibiotic-resistant biofilms, which facilitate chronic infections in immunocompromised hosts. We have previously shown that secretes outer-membrane vesicles that deliver a small RNA to human airway epithelial cells (AECs), in which it suppresses the innate immune response. Here, we demonstrate that interdomain communication through small RNA-containing membrane vesicles is bidirectional and that microRNAs (miRNAs) in extracellular vesicles (EVs) secreted by human AECs regulate protein expression, antibiotic sensitivity, and biofilm formation by Specifically, human EVs deliver miRNA let-7b-5p to , which systematically decreases the abundance of proteins essential for biofilm formation, including PpkA and ClpV1-3, and increases the ability of beta-lactam antibiotics to reduce biofilm formation by targeting the beta-lactamase AmpC. Let-7b-5p is bioinformatically predicted to target not only PpkA, ClpV1, and AmpC in but also the corresponding orthologs in , another notorious opportunistic lung pathogen, suggesting that the ability of let-7b-5p to reduce biofilm formation and increase beta-lactam sensitivity is not limited to Here, we provide direct evidence for transfer of miRNAs in EVs secreted by eukaryotic cells to a prokaryote, resulting in subsequent phenotypic alterations in the prokaryote as a result of this interdomain communication. Since let-7-family miRNAs are in clinical trials to reduce inflammation and because chronic lung infections are associated with a hyperinflammatory state, treatment with let-7b-5p and a beta-lactam antibiotic in nanoparticles or EVs may benefit patients with antibiotic-resistant infections.
是一种机会致病菌,可形成抗生素耐药性生物膜,这有助于在免疫功能低下的宿主中引发慢性感染。我们之前已经表明, 会分泌外膜囊泡,这些囊泡将一种小RNA递送至人气道上皮细胞(AEC),在该细胞中它会抑制先天免疫反应。在此,我们证明通过含小RNA的膜囊泡进行的结构域间通讯是双向的,并且人AEC分泌的细胞外囊泡(EV)中的微小RNA(miRNA)通过 调节蛋白质表达、抗生素敏感性和生物膜形成。具体而言,人EV将miRNA let-7b-5p递送至 ,这会系统性地降低生物膜形成所必需的蛋白质丰度,包括PpkA和ClpV1-3,并增强β-内酰胺类抗生素通过靶向β-内酰胺酶AmpC来减少生物膜形成的能力。通过生物信息学预测,let-7b-5p不仅靶向 的PpkA、ClpV1和AmpC,还靶向另一种臭名昭著的机会性肺部病原体 的相应直系同源物,这表明let-7b-5p减少生物膜形成和增加β-内酰胺敏感性的能力并不局限于 。在此,我们提供了真核细胞分泌的EV中的miRNA转移至原核生物的直接证据,这种结构域间通讯导致了原核生物随后的表型改变。由于let-7家族miRNA正在进行减少炎症的临床试验,并且因为慢性 肺部感染与高炎症状态相关,用纳米颗粒或EV中的let-7b-5p和β-内酰胺类抗生素进行治疗可能会使患有抗生素耐药性 感染的患者受益。